Earnings Call · Q4 FY2024·2025-03-04

Q4 24EPS n/a·Rev n/aQ3 24EPS n/a·Rev n/aQ2 24EPS n/a·Rev n/aQ1 24EPS n/a·Rev n/a⚠ consensus missing

CUMBERLAND PHARMACEUTICALS INC CPIX

Molly Aggas — Account Supervisor

A.J. Kazimi — Chief Executive Officer

Todd Anthony — President

John Hamm — Chief Financial Officer

+11.9%1d on move date+10.8% vs SPY3d+5.3%5d−14.5%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CPIX calls or request research access.

More CPIX calls Browse calls Request research access